Citations

Showing 10 of 108094 citations.

Out-of-Pocket Cost Burden Associated With Contemporary Management of Advanced Prostate Cancer Among Commercially Insured Patients
Sharma, Vidit , Jiang, David H. , Houten, Holly K. Van , Sangaralingham, Lindsey R. , Kwon, Eugene D., Dusetzina, Stacie B. , Tilburt, Jon C. , Boorjian, Stephen A. , Joyce, Daniel D , Borah, Bijan J. , Dusetzina, Stacie , Joyce, Daniel , Penson, David F.

Mayo Clinic

Journal of Urology | September 12, 2022 | Volume: 208 | Issue: 5 | Pages: 987-996

10.1097/ju.0000000000002856 | PMID 36094864 Get It

Perioperative Bleeding Associated With Ibrutinib in Dermatologic Surgery: A Case–Control Study
Aghazadeh, Nessa , Jin, Mauricio F. , Pride, Renee, O’Byrne, Jamie, Vidal, Nahid Y. , Pride, Renee L, Aghazadeh Mohandesi, Nessa

Mayo Clinic

Dermatologic Surgery | September 12, 2022 | Volume: 48 | Issue: 11 | Pages: 1166-1170

10.1097/dss.0000000000003590 | PMID 36095288 Get It

BACKGROUND Ibrutinib, an irreversible Bruton tyrosine kinase inhibitor, has been associated with an increased risk of bleeding. There is a paucity of data on the risk of bleeding in patients on ibrutinib undergoing dermatologic surgery. OBJECTIVE To determine the frequency of bleeding complications associated with ibrutinib in patients undergoing dermatologic surgery. MATERIALS AND METHODS A retrospective, single-center, case–control study of patients on ibrutinib undergoing skin surgery between January 2013 and March 2020 compared with sex, disease, and age-matched control patients undergoing cutaneous surgeries. RESULTS A total of 75 surgeries performed on 37 case patients and 116 surgeries performed on 64 control patients were included. Ibrutinib was associated with a statistically significant increased rate of bleeding events (6/75 [8%] vs 1/116 [0.8%], p -value = .02). Compared with ibrutinib patients who did not have a bleeding event, those on ibrutinib who suffered bleeding were all men, older (mean age 82.7 vs 73.0, p -value= .01), and had lower mean platelet counts (104.0 vs 150.5 K/μL, p -value = .03). CONCLUSION Ibrutinib may be associated with increased risk of bleeding in patients with hematologic malignancies, particularly older men with lower platelet levels and on multiple anticoagulants. Transient discontinuation of ibrutinib should be considered for dermatologic surgeries.
Author Reply to Peer Reviews of Mitochondrial MICOS complex genes, implicated in hypoplastic left heart syndrome, maintain cardiac contractility and actomyosin integrity
Birker, Katja , Kalvakuri, Sreehari , Grossfeld, Paul , Colas, Alexandre R. , Bodmer, Rolf , Kirkland, Natalie J. , Theis, Jeanne L. , Fogarty, Zachary C. , Missinato, Maria A , Engler, Adam Jeffrey , Ocorr, Karen , Nelson, Timothy J. , Olson, Timothy M. , Vogler, Georg

Mayo Clinic

No container title available | September 12, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.15252/rc.2022860709 Get It

Evaluation of Free Valproate Concentration in Critically Ill Patients
Brown, Caitlin S. , Liu, JiTong, Riker, Richard R. , Mara, Kristin C. , May, Teresa , Seder, David B. , Gagnon, David J. , Mara, Kristin C , Rabinstein, Alejandro A. , Fraser, Gilles L.

Mayo Clinic

Critical Care Explorations | September 12, 2022 | Volume: 4 | Issue: 9 | Pages: e0746

10.1097/cce.0000000000000746 | PMID 37942235 Get It

OBJECTIVES: Protein binding of valproate is variable in ICU patients, and the total valproate concentration does not predict the free valproate concentration, even when correcting for albumin. We sought to quantify valproate free concentration among ICU patients, identify risk factors associated with an increasing free valproate concentration, and evaluate the association between free valproate concentration with potential adverse drug effect. DESIGN: Retrospective multicenter cohort study. SETTING: Two academic medical centers. PATIENTS: Patients greater than or equal to 18 years of age with concomitant free and total valproate concentrations collected in the ICU. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Two-hundred fifty-six patients were included in the study, with a median age of 56 years (42–70) and 65% of patients were male. The median total valproate concentration was 53 µg/mL (38–70 µg/mL), the free valproate concentration was 12 µg/mL (7–20 µg/mL), and the free fraction was 23.6% (17.0–33.9%). Therapeutic discordance between the free and total valproate concentration occurred in 70% of patients. On multivariable analysis, increased free valproate concentration was associated with higher total valproate concentration (per 5 µg/mL increase, increase 1.72 µg/mL, 95% CI, 1.48–1.96) and lower serum albumin (per 1 g/dL decrease, increase 4.60 µg/mL, 95% CI, 2.71–6.49). There was no association between free valproate concentration and adverse effects. CONCLUSIONS: The valproate total and free concentration was discordant in the majority of patients (70%). Increased valproate free concentration was associated with hypoalbuminemia and total valproate concentration. Clinical decisions based on total valproate concentration may be incorrect for many ICU patients. Prospective, controlled studies are needed to confirm these findings and their clinical relevance.
Trigger Point Injections Followed by Immediate Myofascial Release in the Treatment of Myofascial Pelvic Pain
Lewis, G.K. , Chen, Anita, Craver, Emily C. , Carrubba, Aakriti R. , Crook, Julia E.

Mayo Clinic

No container title available | September 12, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-2027419/v1 Get It

Abstract Purpose Pelvic floor physical therapy (PFPT) is first line therapy for treatment of myofascial pelvic pain (MFPP). Pelvic floor trigger point injections (PFTPI) are added if symptoms are refractive to conservative therapy or if patients experience a flare. The primary objective was to determine if a session of physical therapy with myofascial release immediately following PFTPI provides improved pain relief compared to trigger point injection alone. Methods This was a retrospective cohort analysis of 87 female patients with MFPP who underwent PFTPI alone or PFTPI immediately followed by PFPT. Visual analog scale (VAS) pain scores were recorded pre-treatment and 2 weeks post-treatment. The primary outcome was the change in VAS between patients who received PFTPI alone and those who received PFTPI followed by myofascial release. Results Of the 87 patients in this study, 22 received PFTPI alone and 65 patients received PFTPI followed by PFPT. The median pre-treatment VAS score was 8 for both groups. The median post-treatment score was 6 for the PFTPI only group and 4 for the PFTPI followed by PFPT group, showing a median change in VAS score of 2 and 4 respectively (p = 0.042). Seventy-seven percent of patients in the PFTPI followed by PFPT group had a VAS score improvement of 3 or more, while 45% of patients in the PFTPI only group had a VAS score improvement greater than 3 (p = 0.008). Conclusions PFTPI immediately followed by PFPT offered more improvement in pain for patients with MFPP. This may be due to greater tolerance of myofascial release immediately following injections.
Changes in physical activity during COVID‐19 pandemic among Saudi Arabians: Results from a cross‐sectional study
Attia, Abdelrahman M. , Elgazzar, Tasnim , Shah, Jaffer , Bajaber, Abubakr , Almustanyir, Sami , Alsaeed, Ruaa Abdullatif, Khalifa, Razan Omer, Hafida, Samar , Ghozy, Sherief , Islam, Sheikh Mohammed Shariful , Shah, Jaffer , Islam, Sheikh Mohammed Shariful , Ghozy, Sherief , Kobeissi, Hassan , Azzam, Ahmed Y

Mayo Clinic

Health Science Reports | September 12, 2022 | Volume: 5 | Issue: 5 | Pages: No page available

10.1002/hsr2.822 | PMID 36110347 Get It

AbstractBackground and AimsThe COVID‐19 pandemic and the resultant change in sedentary behaviors have had immense health, economic, and social implications globally. As governments worldwide imposed lockdowns and curfews, the amount of time spent indoors greatly increased. This lead to a dramatic change in physical activity (PA) levels and profound consequences on daily routines. Our study aimed to investigate patterns of PA during the COVID‐19 pandemic among adults residing in Saudi Arabia.MethodsThis cross‐sectional survey‐based study aimed to investigate patterns of PA during the COVID‐19 pandemic among adults residing in Saudi Arabia. The International Physical Activity Questionnaire was utilized to measure participants' PA levels between April 2021 and May 2021. Participants were then classified into three groups according to their PA level, and their PA levels and sedentary behaviors were analyzed.ResultsWe surveyed 463 participants, 315 (68%) of which were female and 134 (32%) of which were male with a median age of 23 (interquartile range, 21–35) years. Moderate‐to‐high PA was reported by 257 (55.7%) of the participants. There was a significant decrease in PA during the COVID‐19 pandemic and resultant lockdowns among the participants (p = 0.04), with higher rates of sedentary behavior among males than females (p = 0.14).ConclusionsThe decline in PA is a profound challenge of the COVID‐19 pandemic that needs to be addressed by health practitioners and policymakers. Our study highlights the decline in PA levels seen during the COVID‐19 pandemic and the importance of promotional programs and interventions to increase PA among the Saudi Arabian population without compromising the essential health restrictions and social distancing.
Racial Differences in Multimorbidity and Comorbidities in Rheumatoid Arthritis
Kronzer, Vanessa L. , Dykhoff, Hayley J. , Stevens, Maria , Myasoedova, Elena , Davis, John M. , Crowson, Cynthia S. , Stevens, Maria A, Kronzer, Vanessa L , Myasoedova, Elena , Davis, John M

Mayo Clinic

Arthritis Care & Research | September 12, 2022 | Volume: 75 | Issue: 1 | Pages: 76-84

10.1002/acr.25020 | PMID 36094853 Get It

ObjectiveTo identify differences in multimorbidity and individual comorbidities among individuals with rheumatoid arthritis (RA), separated by race and ethnicity.MethodsThis case–control study within OptumLabs Data Warehouse from 2010 to 2019 matched RA cases (defined by 2 codes plus prescription of an RA drug) to non‐RA controls 1:1 on age, sex, race and ethnicity, region, index date of RA, and insurance coverage duration. We defined multimorbidity as the presence of ≥2 or ≥5 validated comorbidities. Logistic regression models calculated adjusted odds of multimorbidity with 95% confidence intervals (95% CIs) within each race and ethnicity.ResultsWe identified 154,391 RA cases and 154,391 controls (mean age 59.6, 76% female). Black enrollees had the most multimorbidity ≥2/≥5 (73.1%, 34.3%); Asian enrollees had the least (52.4%, 17.3%). Adjusted odds of multimorbidity ≥2 and ≥5 in RA cases versus controls was 2.19 (95% CI 2.16–2.23) and 2.06 (95% CI 2.02–2.09), respectively. This increase was similar across race and ethnicity. However, we observed elevated occurrence of certain comorbidities by race and ethnicity versus controls (P < 0.001), including renal disease in White enrollees (4.7% versus 3.2%) and valvular heart disease in Black and White enrollees (3.2% and 2.8% versus 2.6% and 2.2%).ConclusionMultimorbidity is a problem for all RA patients. Targeted identification of certain comorbidities by race and ethnicity may be a helpful approach to mitigate multimorbidity.
Model‐based image reconstruction with wavelet sparsity regularization for through‐plane resolution restoration in T2‐weighted spin‐echo prostate MRI
Borisch, Eric A. , Froemming, Adam T. , Grimm, Roger C., Trzasko, Joshua D. , Riederer, Stephen J. , Riederer, Stephen J , Kawashima, Akira

Mayo Clinic

Magnetic Resonance in Medicine | September 12, 2022 | Volume: 89 | Issue: 1 | Pages: 454-468

10.1002/mrm.29447 | PMID 36093998 Get It

PurposeThe purpose is to develop a model‐based image‐reconstruction method using wavelet sparsity regularization for maintaining restoration of through‐plane resolution but with improved retention of SNR versus linear reconstruction using Tikhonov (TK) regularization in high through‐plane resolution (1 mm) T2‐weighted spin‐echo (T2SE) images of the prostate.MethodsA wavelet sparsity (WS)–regularized image reconstruction was developed that takes as input a set of ≈80 overlapped 3‐mm‐thick slices acquired using a T2SE multislice scan and typically 30 coil elements. After testing in contrast and resolution phantoms and calibration in 6 subjects, the WS reconstruction was evaluated in 16 consecutive prostate T2SE MRI exams. Results reconstructed with nominal 1‐mm thickness were compared with those from the TK reconstruction with the same raw data. Results were evaluated radiologically. The ratio of magnitude of prostate signal to periprostatic muscle signal was used to assess the presence of noise reduction. Technical performance was also compared with a commercial 3D‐T2SE sequence.ResultsThe new WS reconstruction was assessed as superior statistically to TK for overall SNR, contrast, and multiple evaluation criteria related to sharpness while retaining the high (1 mm) through‐plane resolution. Wavelet sparsity tended to provide improved overall diagnostic quality versus TK, but not significantly so. In all 16 studies, the prostate‐to‐muscle signal ratio increased.ConclusionsModel‐based WS‐regularized reconstruction consistently provides improved SNR in high (1 mm) through‐plane resolution images of prostate T2SE MRI versus linear reconstruction using TK regularization.
Histoplasma capsulatum Complement Fixation and Immunodiffusion Assay Sensitivity in Culture-Confirmed Cases of Histoplasmosis: a 10-Year Retrospective Review (2011 to 2020)
Harring, Julie, Kubbara, Aahd , Theel, Elitza S. , Misra, Anisha , Harring, Julie A, Theel, Elitza S , Fida, Madiha

Mayo Clinic

Journal of Clinical Microbiology | September 12, 2022 | Volume: 60 | Issue: 10 | Pages: No page available

10.1128/jcm.01057-22 | PMID 36094192 Get It

The detection of antibodies against Histoplasma capsulatum remains a frequently relied-on approach to diagnose histoplasmosis. We retrospectively assessed the performances of complement fixation (CF) and immunodiffusion (ID) assays for anti- Histoplasma antibody detection in patients with culture-confirmed histoplasmosis at Mayo Clinic (Rochester, MN) over a 10-year period (2011 to 2020).
Response-adapted approach in newly diagnosed myeloma: when less is at least equal
Manasanch, Elisabet E. , Gertz, Morie A.

Mayo Clinic

Leukemia & Lymphoma | September 12, 2022 | Volume: 63 | Issue: 9 | Pages: 2021-2022

10.1080/10428194.2022.2119829 | PMID 36093592 Get It